Drug Type Small molecule drug |
Synonyms PAC 14028, PAC-14028 |
Target |
Action antagonists |
Mechanism TRPV1 antagonists(Transient receptor potential cation channel subfamily V member 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H22F5N3O3S |
InChIKeyUKGJZDSUJSPAJL-YPUOHESYSA-N |
CAS Registry1005168-10-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mild Atopic Dermatitis | Phase 3 | United States | 01 Nov 2016 | |
Moderate Atopic Dermatitis | Phase 3 | United States | 01 Nov 2016 | |
Acne Vulgaris | Phase 3 | - | - | |
Pruritus | Phase 3 | - | - | |
Dermatitis, Seborrheic | Phase 2 | - | 01 Feb 2014 | |
Rosacea | Phase 2 | United States | 01 Feb 2013 |